(Q29620281)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=8479522

30 April 2017

0 references

1 reference

Lowe SW

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=8479522

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=8479522

30 April 2017

Schmitt EM

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=8479522

30 April 2017

Smith SW

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=8479522

30 April 2017

Osborne BA

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=8479522

30 April 2017

Jacks T

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=8479522

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

29 April 1993

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=8479522

30 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=8479522

30 April 2017

volume

362

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=8479522

30 April 2017

issue

6423

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=8479522

30 April 2017

page(s)

847-9

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=8479522

p53 mutations in human cancers

30 April 2017

cites work

1 reference

7 January 2021

The p53 tumour suppressor gene

1 reference

7 January 2021

Presence of a potent transcription activating sequence in the p53 protein

1 reference

7 January 2021

Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene

1 reference

7 January 2021

Wild-type p53 activates transcription in vitro

1 reference

7 January 2021

Oncogenic forms of p53 inhibit p53-regulated gene expression

1 reference

7 January 2021

Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element

1 reference

7 January 2021

Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53

1 reference

7 January 2021

Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.

1 reference

7 January 2021

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

1 reference

7 January 2021

Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53.

1 reference

7 January 2021

Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein

1 reference

7 January 2021

Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.

1 reference

7 January 2021

p53 functions as a cell cycle control protein in osteosarcomas

1 reference

7 January 2021

Suppression of human colorectal carcinoma cell growth by wild-type p53

1 reference

7 January 2021

Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

1 reference

7 January 2021

Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.

1 reference

7 January 2021

Programmed death of autoreactive thymocytes.

1 reference

7 January 2021

Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation

1 reference

7 January 2021

Contingent genetic regulatory events in T lymphocyte activation

1 reference

7 January 2021

Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures

1 reference

7 January 2021

Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis.

1 reference

7 January 2021

bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes

1 reference

7 January 2021

bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship

1 reference

7 January 2021

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

1 reference

7 January 2021

Cancer. p53, guardian of the genome

1 reference

7 January 2021

bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation

1 reference

7 January 2021

Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.

1 reference

7 January 2021

Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation

1 reference

7 January 2021

Transgenesis by means of blastocyst-derived embryonic stem cell lines

1 reference

7 January 2021

Genetic analysis of susceptibility to radiation-induced apoptosis of thymocytes in mice

1 reference

7 January 2021

Identification of deoxyribonuclease II as an endonuclease involved in apoptosis

1 reference

7 January 2021

Monoclonal antibody analysis of p53 expression in normal and transformed cells

1 reference

7 January 2021

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=8479522

Identifiers

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1032575717

0 references

1 reference

Consolidated OpenCitations Corpus – April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=8479522

PubMed publication ID

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017